Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: LAULIMA GOVERNMENT SOLUTIONS, LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-09-30 to 2027-09-29
Current total value of award: $1169925.8
Description: COMBINED LONG TERM EFFEROCYTOSIS AND ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY RESPONSE HIV VACCINE CLINICAL TRIAL TO INVESTIGATE SAFETY AND IMMUNOGENICITY OF NEW VACCINE CANDIDATES IN SUPPORT OF THE WAR FIGHTER.